Cabinet nod to ₹9,589 cr FDI in Suven Pharma; stock surges 5%
Cabinet approves FDI worth up to ₹9,589 cr in Suven by Cyprus-based Berhyanda for a 76.1% stake
suven pharmaceuticals
September 2023
December 2022
Suven Pharma stock rises 4% on acquisition by Advent International
Advent plans to merge its portfolio company Cohance Lifesciences with Suven to build an end-to-end CDMO and merchant API.
